Biotech · Private company · Cambridge, MA, US
Velum, Inc.
Track this companyFree. Adds Velum, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Peptide YY triagonist weight loss drugsFiscal year 2025 · $315.3KNIH RePORTER 1R41DK145340-01 · fetched Nov 12, 2026
- A Robust Platform for Design and Development of Therapeutic Peptides for Metabolic SyndromeFiscal year 2025 · $959KNIH RePORTER 5R42DK131842-03 · fetched Nov 12, 2026
- A Robust Platform for Design and Development of Therapeutic Peptides for Metabolic SyndromeFiscal year 2024 · $1.1MNIH RePORTER 2R42DK131842-02 · fetched Nov 12, 2026